These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 8749845)
1. Docking of a human rhinovirus neutralizing antibody onto the viral capsid. Tormo J; Centeno NB; Fontana E; Bubendorfer T; Fita I; Blaas D Proteins; 1995 Dec; 23(4):491-501. PubMed ID: 8749845 [TBL] [Abstract][Full Text] [Related]
2. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2. Tormo J; Stadler E; Skern T; Auer H; Kanzler O; Betzel C; Blaas D; Fita I Protein Sci; 1992 Sep; 1(9):1154-61. PubMed ID: 1338980 [TBL] [Abstract][Full Text] [Related]
3. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2. Hewat EA; Blaas D EMBO J; 1996 Apr; 15(7):1515-23. PubMed ID: 8612574 [TBL] [Abstract][Full Text] [Related]
4. Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop. Hewat EA; Verdaguer N; Fita I; Blakemore W; Brookes S; King A; Newman J; Domingo E; Mateu MG; Stuart DI EMBO J; 1997 Apr; 16(7):1492-500. PubMed ID: 9130694 [TBL] [Abstract][Full Text] [Related]
5. Structure of human rhinovirus serotype 2 (HRV2). Verdaguer N; Blaas D; Fita I J Mol Biol; 2000 Jul; 300(5):1179-94. PubMed ID: 10903863 [TBL] [Abstract][Full Text] [Related]
6. Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2. Tormo J; Blaas D; Parry NR; Rowlands D; Stuart D; Fita I EMBO J; 1994 May; 13(10):2247-56. PubMed ID: 8194515 [TBL] [Abstract][Full Text] [Related]
7. Structure determination of an Fab fragment that neutralizes human rhinovirus 14 and analysis of the Fab-virus complex. Liu H; Smith TJ; Lee WM; Mosser AG; Rueckert RR; Olson NH; Cheng RH; Baker TS J Mol Biol; 1994 Jul; 240(2):127-37. PubMed ID: 8027997 [TBL] [Abstract][Full Text] [Related]
8. Flexibility of the major antigenic loop of foot-and-mouth disease virus bound to a Fab fragment of a neutralising antibody: structure and neutralisation. Verdaguer N; Schoehn G; Ochoa WF; Fita I; Brookes S; King A; Domingo E; Mateu MG; Stuart D; Hewat EA Virology; 1999 Mar; 255(2):260-8. PubMed ID: 10069951 [TBL] [Abstract][Full Text] [Related]
9. Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody. Smith TJ; Olson NH; Cheng RH; Liu H; Chase ES; Lee WM; Leippe DM; Mosser AG; Rueckert RR; Baker TS J Virol; 1993 Mar; 67(3):1148-58. PubMed ID: 7679742 [TBL] [Abstract][Full Text] [Related]
10. Bivalent binding of a neutralising antibody to a calicivirus involves the torsional flexibility of the antibody hinge. Thouvenin E; Laurent S; Madelaine MF; Rasschaert D; Vautherot JF; Hewat EA J Mol Biol; 1997 Jul; 270(2):238-46. PubMed ID: 9236125 [TBL] [Abstract][Full Text] [Related]
11. Structure of a neutralizing antibody bound monovalently to human rhinovirus 2. Hewat EA; Marlovits TC; Blaas D J Virol; 1998 May; 72(5):4396-402. PubMed ID: 9557730 [TBL] [Abstract][Full Text] [Related]
12. Nonneutralizing human rhinovirus serotype 2-specific monoclonal antibody 2G2 attaches to the region that undergoes the most dramatic changes upon release of the viral RNA. Hewat EA; Blaas D J Virol; 2006 Dec; 80(24):12398-401. PubMed ID: 17005641 [TBL] [Abstract][Full Text] [Related]
13. A disulfide-bound HIV-1 V3 loop sequence on the surface of human rhinovirus 14 induces neutralizing responses against HIV-1. Zhang A; Geisler SC; Smith AD; Resnick DA; Li ML; Wang CY; Looney DJ; Wong-Staal F; Arnold E; Arnold GF Biol Chem; 1999 Mar; 380(3):365-74. PubMed ID: 10223339 [TBL] [Abstract][Full Text] [Related]
14. A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2. Skern T; Neubauer C; Frasel L; Gründler P; Sommergruber W; Zorn M; Kuechler E; Blaas D J Gen Virol; 1987 Feb; 68 ( Pt 2)():315-23. PubMed ID: 2434607 [TBL] [Abstract][Full Text] [Related]
15. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon. Smith TJ; Chase ES; Schmidt TJ; Olson NH; Baker TS Nature; 1996 Sep; 383(6598):350-4. PubMed ID: 8848050 [TBL] [Abstract][Full Text] [Related]
16. Attachment of neutralizing antibodies stabilizes the capsid of poliovirus against uncoating. Wetz K Virology; 1993 Feb; 192(2):465-72. PubMed ID: 8380661 [TBL] [Abstract][Full Text] [Related]
17. Crystallization and preliminary X-ray diffraction studies of a monoclonal antibody Fab fragment against foot-and-mouth disease virus and of its complex with the main antigenic site peptide. Verdaguer N; Mateu MG; Bravo J; Tormo J; Giralt E; Andreu D; Domingo E; Fita I Proteins; 1994 Feb; 18(2):201-3. PubMed ID: 8159669 [TBL] [Abstract][Full Text] [Related]
18. Localization of membrane permeabilization and receptor binding sites on the VP4 hemagglutinin of rotavirus: implications for cell entry. Tihova M; Dryden KA; Bellamy AR; Greenberg HB; Yeager M J Mol Biol; 2001 Dec; 314(5):985-92. PubMed ID: 11743716 [TBL] [Abstract][Full Text] [Related]
19. Neutralizing antibodies to human rhinovirus produced in laboratory animals and humans that recognize a linear sequence from VP2. Hastings GZ; Speller SA; Francis MJ J Gen Virol; 1990 Dec; 71 ( Pt 12)():3055-9. PubMed ID: 1703215 [TBL] [Abstract][Full Text] [Related]
20. Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy. Prasad BV; Burns JW; Marietta E; Estes MK; Chiu W Nature; 1990 Feb; 343(6257):476-9. PubMed ID: 2153941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]